Using market-exclusivity incentives to promote pharmaceutical innovation

N Engl J Med. 2010 Nov 4;363(19):1855-62. doi: 10.1056/NEJMhle1002961.

Author

Aaron S Kesselheim¹

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA. akesselheim@partners.org

PMID: 21047231
DOI: 10.1056/NEJMhle1002961

No abstract available

Publication types

Historical Article
Research Support, Non-U.S. Gov't

MeSH terms

Biomedical Research / history
Biomedical Research / legislation & jurisprudence
Drug Discovery / history*
Drug Discovery / legislation & jurisprudence
Drug Industry / history*
Drug Industry / legislation & jurisprudence
History, 20th Century
Legislation, Drug / history*
Patents as Topic / history*
Patents as Topic / legislation & jurisprudence
Prescription Drugs / history
Public Policy / history
United States

Substances

Prescription Drugs